You will receive alerts when there are new announcements on Paradigm Biopharmaceuticals Ltd
Only registered members can use this feature.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) is listed on the Australian Securities Exchange.
The injectable PPS trial has had a clinically meaningful and statistically significant result in patients with arthritic knee pain.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.